ASNR21 Virtual: Special Symposium Speaker: Cancer Disparities & COVID-19

Description

IF YOU DO NOT SEE THE LAUNCH BUTTON ABOVE, PLEASE LOGIN AND RETURN TO THIS PAGE.

RELEASE DATE: 5/23/2021
EXPIRATION DATE: 5/23/2024

INSTRUCTIONS FOR PARTICIPATION

To complete this activity, learners will watch a video and submit a course evaluation. Once all elements are completed, a certificate will be provided in the Completed Courses section of the My Learning tab. A transcript of all completed sessions and courses is available to download on the Completed Courses page.

DESCRIPTION

This session will review cancer and Covid-19 health disparities.

LEARNING OBJECTIVES

Upon completion of this activity, participants will have strategies to:

• Recognize cancer health disparities and their effects on health.
• Understand the influence of cancer diagnoses in the risk of Covid-19 infection.
• Review recommendations for achieving health equity to mitigate the potential impact of Covid-19 on preexisting cancer treatment disparities.

AGENDA

Planner: Tina Young Poussaint, MD, FACR
Moderator: Michele Johnson, MD, FACR Introduction
Johnson B. Lightfoote, MD, FACR Cancer Disparities & COVID-19
Otis W, Brawley, MD, MACP, FASCO, FACE

ACCREDITATION STATEMENT

The American Society of Neuroradiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Neuroradiology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SPEAKER & MODERATOR DISCLOSURE INDEX

Michele Johnson, MD, FACR: IschiemiaView, Scientific/Medical Advisory Board Member
Johnson B. Lightfoote, MD, FACR: Nothing to disclose
Otis W, Brawley, MD, MACP, FASCO, FACE: Lyell Immunopharma, Corporate Board Member; PDSs Bioscience, Corporate Board Member; Grail, Consultant; Jackson Laboratories, Corporate Board Member; Genentech/Roche, Consultant

PLANNER & PROGRAM COMMITTEE DISCLOSURE INDEX

Tina Young Poussaint, MD, FACR: NIH: Pediatric Brain Tumor Consortium Neuroimaging Center Grant, Research Grant Site Principal Investigator; Springer Publishing, Other Financial or Material Support
Chang, Peter: Avicenna.ai, Stock shareholder
Johnson, Michele: IschiemiaView, Scientific/Medical Advisory Board Member
Lev, Michael: Takeda Pharm, Consultant; GE Healthcare, Research Grant Site Principal Investigator
Poussaint, Tina Young: NIH: Pediatric Brain Tumor Consortium Neuroimaging Center Grant, Research Grant Site Principal Investigator; Springer Publishing, Other Financial or Material Support
Schwartz, Erin Simon: Applied Radiology, Editor in Chief

All other planners and Program Committee members have nothing to disclose.